These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 36038961)

  • 1. Computational investigation of peptidomimetics as potential inhibitors of SARS-CoV-2 spike protein.
    Tarek Ibrahim M; Tao P
    J Biomol Struct Dyn; 2023; 41(15):7144-7157. PubMed ID: 36038961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein.
    Rabbani G; Ahn SN; Kwon H; Ahmad K; Choi I
    Biochem Biophys Rep; 2021 Dec; 28():101170. PubMed ID: 34778573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer.
    Bharathi M; Sivamaruthi BS; Kesika P; Thangaleela S; Chaiyasut C
    Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulations of the spike trimeric ectodomain of the SARS-CoV-2 Omicron variant: structural relationships with infectivity, evasion to immune system and transmissibility.
    de Souza AS; Amorim VMF; de Souza RF; Guzzo CR
    J Biomol Struct Dyn; 2023 Nov; 41(19):9326-9343. PubMed ID: 36345794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
    Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
    Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2.
    Gollapalli P; B S S; Rimac H; Patil P; Nalilu SK; Kandagalla S; Shetty P
    J Biomol Struct Dyn; 2022 Apr; 40(6):2701-2714. PubMed ID: 33146070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
    Lata S; Akif M
    J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomistic insights into the binding of SARS-CoV-2 spike receptor binding domain with the human ACE2 receptor: The importance of residue 493.
    Carter C; Airas J; Parish CA
    J Mol Graph Model; 2023 Jan; 118():108360. PubMed ID: 36401897
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Wu J; Zhang HX; Zhang J
    Phys Chem Chem Phys; 2023 May; 25(21):14711-14725. PubMed ID: 37199217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV 2 spike protein S1 subunit as an ideal target for stable vaccines: A bioinformatic study.
    S N N; B N R; C P; K S S; Ramakrishnappa T; B T K; S M J; M M; N A; Yallappa ; D DP; T V R; E G; Bagoji M; Chandaragi SS
    Mater Today Proc; 2022; 49():904-912. PubMed ID: 34307057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Binding between Omicron B.1.1.529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2.
    Hoffman T; Kolstad L; Akaberi D; Järhult JD; Rönnberg B; Lundkvist Å
    Viruses; 2023 May; 15(6):. PubMed ID: 37376580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2.
    Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT
    J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach.
    Hakami AR
    Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity.
    Ridgway H; Ntallis C; Chasapis CT; Kelaidonis K; Matsoukas MT; Plotas P; Apostolopoulos V; Moore G; Tsiodras S; Paraskevis D; Mavromoustakos T; Matsoukas JM
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851526
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody.
    Omotuyi O; Olubiyi O; Nash O; Afolabi E; Oyinloye B; Fatumo S; Femi-Oyewo M; Bogoro S
    Comput Biol Med; 2022 Mar; 142():105226. PubMed ID: 35066447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein.
    Otsubo R; Minamitani T; Kobiyama K; Fujita J; Ito T; Ueno S; Anzai I; Tanino H; Aoyama H; Matsuura Y; Namba K; Imadome KI; Ishii KJ; Tsumoto K; Kamitani W; Yasui T
    Sci Rep; 2022 Nov; 12(1):20120. PubMed ID: 36418391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants.
    Mamedov T; Yuksel D; Gurbuzaslan I; Gulec B; Mammadova G; Ozdarendeli A; Pavel STI; Yetiskin H; Kaplan B; Uygut MA; Hasanova G
    Front Plant Sci; 2023; 14():1290042. PubMed ID: 38034565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach.
    Mathew SM; Benslimane F; Althani AA; Yassine HM
    Qatar Med J; 2021; 2021(1):12. PubMed ID: 34604010
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies.
    Samanta A; Alam SSM; Ali S; Hoque M
    Funct Integr Genomics; 2023 Jan; 23(1):36. PubMed ID: 36631570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.